>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
血清外泌体miRNA-223在宫颈癌诊断及预后评价中的价值研究
作者:蒋露  周静  唐姣 
单位:湖南省妇幼保健院 妇产科, 湖南 长沙 410008
关键词:血清 外泌体 miRNA-223 宫颈癌 诊断 预后 
分类号:R737.33
出版年·卷·期(页码):2021·40·第一期(52-57)
摘要:

目的:探讨血清外泌体miRNA-223在宫颈癌诊断及预后评价中的价值。方法:采用RT-PCR法检测168例宫颈癌患者(宫颈癌组)和160例健康人(对照组)血清外泌体miRNA-223的表达水平,受试者工作特征(ROC)曲线分析miRNA-223诊断宫颈癌的价值,计算曲线下面积(AUC)、诊断灵敏度和特异度;Kaplan-Meier法比较miRNA-223高表达患者和低表达患者的总体生存时间;Cox比例风险模型分析影响宫颈癌患者预后的因素。结果:宫颈癌组血清外泌体miRNA-223的相对表达量为2.26±0.68,明显高于对照组的0.89±0.21,差异有统计学意义(t=23.199,P<0.001)。血清外泌体miRNA-223诊断宫颈癌AUC为0.928(95%CI:0.867~0.976),灵敏度和特异度分别为86.55%和94.37%。血清外泌体miRNA-223表达水平与FIGO分期、淋巴结转移和宫颈浸润深度有关(P<0.0.5)。FIGO分期Ⅱb~Ⅲa、淋巴结转移、宫颈浸润深度≥2/3、miRNA-223高表达是宫颈癌患者总生存期和无病生存期的独立影响因素(P<0.05)。结论:血清外泌体miRNA-223对宫颈癌的早期诊断及预后判断有一定价值,其表达水平越高,患者的生存预后越差。

Objective: To investigate the value of serum exosome miRNA-223 in the diagnosis and prognosis of cervical cancer. Methods: 168 patients with cervical cancer (cervical cancer group) and 160 healthy people (control group) were studied. The expression of miRNA-223 in serum exosomes was detected by RT-PCR. The value of miRNA-223 in the diagnosis of cervical cancer was analyzed by ROC curve. The area under curve (AUC), diagnostic sensitivity and specificity were calculated. Kaplan-Meier method was used to compare the overall survival time of patients with high and low miRNA-223 expression. Cox proportional risk model was used to analyze the prognostic factors of cervical cancer patients. Results: The relative expression of miRNA-223 in the cervical cancer group was 2.26±0.68, which was significantly higher than that in the control group (0.89±0.21,t=23.199, P<0.001). The area under ROC curve was 0.928 (95% CI:0.867-0.976), the sensitivity and specificity were 86.55% and 94.37%, respectively. The expression level of miRNA-223 in exosomes was associated with FIGO stage, lymph node metastasis and cervical infiltration depth (P<0.0.5). FIGO stage Ⅱ b-Ⅲ a, lymph node metastasis, cervical invasion depth ≥ 2/3, and high expression of miRNA-223 were independent factors of total and disease-free survival of cervical cancer patients (P<0.05). Conclusion: Serum exosomes miRNA-223 is valuable for early diagnosis and prognosis of cervical cancer. The higher the expression level of exosomes miRNA-223 is, the worse the survival prognosis gets.

参考文献:

[1] JOHNSON C A,JAMES D,MARZAN A,et al.Cervical cancer:an overview of pathophysiology and management[J].Semin Oncol Nurs,2019,35(2):166-174.
[2] BEDELL S L,GOLDSTEIN L S,GOLDSTEIN A R,et al.Cervical cancer screening:past,present,and future[J].Sex Med Rev,2019,26(1):1-9.
[3] 杨展威,杨毓斌,余洛海.骨肉瘤中微小RNA的功能研究进展[J].现代医学,2017,45(9):1367-1371.
[4] GAO C,ZHOU C,ZHUANG J,et al.MicroRNA expression in cervical cancer:novel diagnostic and prognostic biomarkers[J].J Cell Biochem,2018,119(8):7080-7090.
[5] ZHANG C,ZHANG J.Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway[J].Exp Ther Med,2018,15(5):4325-4331.
[6] YOSHIKAWA M,ⅡNUMA H,UMEMOTO Y,et al.Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer[J].Oncol Lett,2018,15(6):9584-9592.
[7] GUO J,CAO R,YU X,et al.MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion[J].Tumour Biol,2017,39(2):1-8.
[8] WU L,LI H,JIA C Y,et al.MicroRNA-223 regulates FOXO1 expression and cell proliferation[J].FEBS Lett,2012,586(7):1038-1043.
[9] DAS A,MOHAN V,KRISHNASWAMY V R,et al.Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression[J].Cancer Metastasis Rev,2019,38(3):455-468.
[10] HE L,ZHU W,CHEN Q,et al.Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis[J].Theranostics,2019,9(26):8206-8220.
[11] WANG W,LIU X,ZHANG F.The characteristics and survival of patients with mesorectum metastatic lymph nodes from cervical cancer[J].Cancer Manag Res,2019,11:10401-10408.
[12] DI J,RUTHERFORD S,CHU C.Review of the cervical cancer burden and population-based cervical cancer screening in China[J].Asian Pac J Cancer Prev,2015,16(17):7401-7407.
[13] WANG H,PENG R,WANG J,et al.Circulating microRNAs as potential cancer biomarkers:the advantage and disadvantage[J].Clinical Epigenetics,2018,10(1):59-65.
[14] YANG Y,JIANG Z,MA N,et al.MicroRNA-223 targeting STIM1 inhibits the biological behavior of breast cancer[J].Cell Physiol Biochem,2018,45(2):856-866.
[15] KURASHIGE J,WATANABE M,IWATSUKI M,et al.Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma[J].Br J Cancer,2012,106(1):182-188.
[16] LI M,LI B Y,XIA H,et al.Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis[J].Eur Rev Med Pharmacol Sci,2017,21(10):2346-2350.
[17] LI Q,WANG Q,ZHANG Q,et al.Collagen prolyl 4-hydroxylase 2 predicts worse prognosis and promotes glycolysis in cervical cancer[J].Am J Transl Res,2019,11(11):6938-6951.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 277670 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364